MAGHA DISSANAYAKE: Open Payments
NPI 1578545182 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,635 in 82 payments from 22 companies in 2025. Trend: 2023 $1,036 · 2024 $988 · 2025 $1,635
Food & beverage: $1,603Education: $32
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $385 |
| AstraZeneca Pharmaceuticals LP | 6 | $246 |
| Novo Nordisk Inc | 11 | $209 |
| GlaxoSmithKline, LLC. | 7 | $160 |
| ABBVIE INC. | 3 | $88 |
| Amgen Inc. | 4 | $79 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Corcept Therapeutics | 3 | $50 |
| Boston Scientific Corporation | 1 | $33 |
Products named: ELIQUIS, FARXIGA, Ozempic, NURTEC ODT, TRELEGY ELLIPTA, ZENPEP, REXULTI, PREVNAR 20.
Industry payments across OR — which companies pay providers there.
